$ALP 4 SEC Filings

Filed On	Filing
13 Oct 2026	Form 4: Villani Fiorenzo, Director Bought 5,150 shares ($19.6K)
05 Oct 2026	Form 4: Mitin Yury, See Remarks Received 4,944 shares as a grant or award · Granted 10,906 Share Options (right to buy) · Bought 3,657 shares ($12.9K) · 2 more
23 Sep 2026	Form 4: Villani Fiorenzo, Director Bought 10,000 shares ($44K)
17 Sep 2026	Form 4: Villani Fiorenzo, Director Bought 4,000 shares ($16.6K) · Bought 18,282 shares ($75.1K) · Bought 4,265 shares ($17.3K)
14 Sep 2026	Form 4: Villani Fiorenzo, Director Received 24,094 shares as a grant or award · Granted 10,906 Option Shares (right to buy) · Bought 7,000 shares ($35.5K)
14 Sep 2026	Form 4: Kaiser Brittany, Director Received 7,416 shares as a grant or award · Granted 10,906 Option Shares (right to buy) · Bought 9,350 shares ($50K)
11 Sep 2026	Form 4: Levitt Wesley Allen, Chief Financial Officer Bought 1,000 shares ($5.1K)
24 Jan 2018	Form 4: Portage Biotech Inc., former 10% owner · Biohaven Pharmaceutical Holding Co Ltd. Sold 35,119 shares ($1.05M) · Sold 24,277 shares ($8.05B)
09 Jan 2018	Form 4: Portage Biotech Inc., 10% owner · Biohaven Pharmaceutical Holding Co Ltd. Sold 22,996 shares ($691K) · Sold 5,728 shares ($172K) · Sold 56,157 shares ($1.69M)
05 Jan 2018	Form 4: Portage Biotech Inc., 10% owner · Biohaven Pharmaceutical Holding Co Ltd. Sold 4,350 shares ($125K)
04 Jan 2018	Form 4: Portage Biotech Inc., 10% owner · Biohaven Pharmaceutical Holding Co Ltd. Sold 35,650 shares ($1.02M)

Comments